If you’re a widow or an orphan, Johnson & Johnson (JNJ) might be the right investment for you.  It’s hard to imagine the juggernaut being pushed off its slow but steady upward course.
On the other hand, if you’re looking for more rapid growth, you might want to look at another company in the health industry, [...]

[Read more →]

Somewhat related to the working world (which I discussed yesterday) is my stock for today, Salesforce.com (CRM), which was featured in Cabot Top Ten Report on August 24. Here’s what Editor Michael Cintolo wrote about Salesforce.com then:
“Salesforce.com was founded a decade ago by a former Oracle executive, and today it’s a leading vendor of Customer [...]

[Read more →]

Today’s investment idea is all about lighting.  No, it’s not those curly compact fluorescents that are filled with MERCURY and require you to evacuate the room if you break one.  The main reason we’ve got those today is that the energy savings sounded good to the folks in Washington and the profits sounded good to [...]

[Read more →]

OK, now that I’ve got those thoughts from yesterday off my chest, I have an investment idea that’s relevant.
It’s Medifast (MED), the purveyor of pre-packaged portion-controlled meals.  The primary market for its products is people who want to lose weight; a secondary and overlapping market is people who want to control Type 2 diabetes.
Back on [...]

[Read more →]

I want to speak up for one big benefit of stock investing that doesn’t get a lot of publicity.
I think it’s fun!
Yes, fun.  And I don’t just mean that making a big killing on a hot stock is fun.
I think the daily drama and the brain work and the blood, sweat and tears of researching, [...]

[Read more →]